Figure 3:
Relapse rates among patients with <5% marrow myeloblasts at time of hematopoietic cell transplantation (HCT) following pre-HCT induction chemotherapy.
Figure originally published in Leukemia.
Scott BL, Sandmaier BM, Storer B, et al. Myeloablative vs nonmyeloablative allogeneic transplantation for patients with myelodysplastic syndrome or acute myelogenous leukemia with multilineage dysplasia: a retrospective analysis. Leukemia 2006;20:128–135.
Used with permission from the authors.
